Kyivstar Group (NASDAQ:KYIV) reported healthy earnings, but the stock price remained largely unchanged. Analysts believe that the company's profit was understated due to unusual items totaling US$166m, which are not expected to repeat. This suggests that Kyivstar Group's future profitability could be significantly higher if these one-off expenses are removed.

Summit Insights has downgraded Applied Materials (AMAT) to Hold from Buy, citing limited upside to the company's fiscal 2027 outlook due to cleanroom constraints. The firm believes that much of the anticipated wafer fab equipment (WFE) market growth is already priced into the shares, with capex intensity expected to favor lithography over etch and deposition in 2027.

Immatics N.V. (NASDAQ:IMTX) reported third-quarter results that fell short of analyst expectations, with revenues missing by 37% and losses slightly higher than modeled. Following the earnings report, analysts have downgraded their revenue forecasts for 2027 and predict increased per-share losses, although the average price target remains unchanged. The company's revenue decline is expected to accelerate, performing worse than the broader industry.

Russell Investments Group Ltd. reduced its stake in Digital Realty Trust, Inc. (NYSE:DLR) by 9.1% in the third quarter, selling 195,520 shares. Despite this, other institutional investors like BlackRock Inc. and Bank of America Corp DE significantly increased their holdings in the data center REIT. The article also covers Digital Realty Trust's recent earnings, dividend announcement, and analyst ratings, which indicate a "Moderate Buy" consensus.

FinVolution Group announced it will release its third quarter 2026 unaudited financial results on November 25, 2026, after U.S. market close. The company will host an earnings conference call on the same day at 7:30 PM ET, requiring online registration for participation. FinVolution, a leading fintech platform since 2007, connects young borrowers with financial institutions and reported 254.2 million registered users as of June 30, 2026.

Ritholtz Wealth Management significantly increased its stake in Salesforce Inc. during the third quarter, acquiring an additional 7,808 shares to bring its total holdings to 22,990 shares valued at approximately $5.28 million. Institutional investors now collectively own 80.43% of the company's stock, reflecting strong confidence in the CRM provider. Salesforce has received a consensus "Moderate Buy" rating from analysts with an average price target of $278.98, following a quarter where it reported EPS of $5.90, well above the consensus, and a 10.8% year-over-year revenue increase to $11.35 billion.

GSI Technology Inc. director Hong-Po Hsieh was granted a stock option for 16,457 common shares on November 10, 2026. The exercise price is $3.19 per share, and the option expires on November 10, 2036. The option vests fully on August 15, 2027, subject to continued service, or immediately upon a Change in Control before that date.

Wells Fargo has initiated coverage on Korsana Biosciences (NASDAQ:KRSA) with an "overweight" rating and a $44 price target, indicating a potential 41% upside. The biotech firm's lead asset, KRSA-028, is being developed for Alzheimer's Disease and utilizes a transferrin receptor shuttle to improve drug delivery and amyloid beta clearance. Other analysts from UBS, Stifel, TD Cowen, and Wedbush have also issued positive ratings, citing the drug's innovative approach and the high unmet need in Alzheimer's treatment.

Eurizon Capital SGR S.p.A. significantly reduced its stake in International Business Machines (IBM) by 65.5% in the third quarter of 2026, selling over 500,000 shares. Despite this, IBM reported strong third-quarter earnings of $2.95 per share and revenue of $17.1 billion, both exceeding analyst estimates. The company also declared a quarterly dividend of $1.69 per share, and analysts maintain a "Moderate Buy" rating with an average price target of $266.88.

Micron Technology (NASDAQ:MU) shares have experienced significant volatility, moving 5% or more on a third of its trading days since October. Despite recent drops, the author believes the stock is worth owning due to its trading at 4.6 times expected fiscal 2027 earnings per share, which already accounts for a potential steep drop in profits. The article recommends limiting Micron to a maximum of 5% of a diversified portfolio to manage risk, especially given the stock's potential for large swings.